Marek Šoltys

Marek Šoltys

Auto-generated profile, based on publicly available information

Marek Šoltys

Department of Chemical Engineering, University of Chemistry and Technology, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Chemical Engineering Journal
Verified
Journal Article
Closed access
MŠMarek Šoltys
Marek Šoltys
MBMartin Balouch
Martin Balouch
OKOndřEj Kašpar
OndřEj Kašpar
MLMiloslav Lhotka
Miloslav Lhotka
PUPavel Ulbrich
Pavel Ulbrich
FŠFrantišek Štěpánek
František Štěpánek

1 May 2018 in Polymer
Verified
Journal Article
Closed access
MLMarek Lanč
Marek Lanč
PSPetr Sysel
Petr Sysel
MŠMarek Šoltys
Marek Šoltys
FŠFrantišek Štěpánek
František Štěpánek
KFKristián Fónod
Kristián Fónod
Karel FriessKarel Friess
Karel Friess

1 May 2017 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
AAAyse Beyza Aysan
Ayse Beyza Aysan
ZKZdeněk Knejzlík
Zdeněk Knejzlík
PUPavel Ulbrich
Pavel Ulbrich
MŠMarek Šoltys
Marek Šoltys
AZAleš Zadražil
Aleš Zadražil
FŠFrantišek Štěpánek
František Štěpánek

8 February 2021 in Molecular Systems Design & Engineering
Verified
Journal Article
Closed access
PDF file
MBMartin Balouch
Martin Balouch
MŠMartin Šrejber
Martin Šrejber
MŠMarek Šoltys
Marek Šoltys
PJPetra Janská
Petra Janská
FŠFrantišek Štěpánek
František Štěpánek
KBKarel Berka
Karel Berka
Liposomal formulations can be advantageous in many scenarios such as targeted delivery to reduce the systemic toxicity of highly potent active pharmaceutical ingredients (APIs), to increase drug bioavailability by prolonging systemic circulation, to protect labile APIs from degradation in the gastrointestinal tract, or to improve skin permeation in dermal delivery. However, not all APIs are suitable for encapsulation in liposomes. Some of the issues are too high permeability of the API across the lipid bilayer, which may lead to premature leakage, too low permeability, which may hinder the drug release process, or too strong membrane affinity, which may reduce the overall efficacy of drug release from liposomes. Since the most reliable way to test API encapsulation and release from liposomes so far has been experimental, an in silico model capable of predicting API transport across the lipid bilayer might accelerate formulation development. In this work, we demonstrate a new in silico approach to compute the temperature-dependent permeability of a set of compounds across the bilayer of virtual liposomes constructed by molecular dynamics simulation. To validate this approach, we have conducted a series of experiments confirming the model predictions using a homologous series of fluorescent dyes. Based on the performance of individual molecules, we have defined a set of selection criteria for identifying compatible APIs for stable encapsulation and thermally controlled release from liposomes. To further demonstrate the in silico-based methodology, we have screened the DrugBank database, identified potent drugs suitable for liposome encapsulation and successfully carried out the loading and thermal release of one of them – the antimicrobial compound cycloserine.

1 July 2016 in Microporous and Mesoporous Materials
Verified
Journal Article
Closed access
MŠMarek Šoltys
Marek Šoltys
PKPavel Kovačík
Pavel Kovačík
MLMiloslav Lhotka
Miloslav Lhotka
PUPavel Ulbrich
Pavel Ulbrich
AZAleš Zadražil
Aleš Zadražil
FŠFrantišek Štěpánek
František Štěpánek

1 November 2021 in Colloids and Surfaces A: Physicochemical and Engineering Aspects
Verified
Journal Article
Closed access
MBMartin Balouch
Martin Balouch
MŠMarek Šoltys
Marek Šoltys
FHFilip Hládek
Filip Hládek
PUPavel Ulbrich
Pavel Ulbrich
FŠFrantišek Štěpánek
František Štěpánek